EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma

Phase 1

Completed

Conditions: Lymphoblastic Leukemia
Lymphoblastic Lymphoma

Interventions: Drug: Everolimus
Drug: Nelarabine
Drug: Cyclophosphamide
Drug: Etoposide

First Posted Date: 2017-11-01

Last Posted Date: 2023-07-21

Lead Sponsor: Emory University

Target Recruit Count: 8

Registration Number: NCT03328104

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Cincinnati Children's Hospital, Cincinnati, Ohio, United States

and more 1 locations

Improving Health Literacy in African-American Prostate Cancer Patients

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Other: Educational Supplement
Other: Standard Practice Education

First Posted Date: 2017-10-26

Last Posted Date: 2020-06-16

Lead Sponsor: Emory University

Target Recruit Count: 160

Registration Number: NCT03322891

Locations: 🇺🇸
Atlanta VA Medical Center, Atlanta, Georgia, United States
🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 1 locations

Usability and Tolerability of Novel Protection Device Against Potential Brain Injury During Competitive Sport

Completed

Conditions: Brain Injuries, Traumatic
Brain Injury Traumatic Mild

Interventions: Device: Q-Collar

First Posted Date: 2017-10-24

Last Posted Date: 2021-05-06

Lead Sponsor: Emory University

Target Recruit Count: 200

Registration Number: NCT03318822

Locations: 🇺🇸
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States

Neostigmine For Snoring During DISE

Early Phase 1

Terminated

Conditions: Snoring

Interventions: Drug: Neostigmine Methylsulfate

First Posted Date: 2017-10-23

Last Posted Date: 2019-07-02

Lead Sponsor: Emory University

Target Recruit Count: 1

Registration Number: NCT03316963

Locations: 🇺🇸
Raj C. Dedhia, Atlanta, Georgia, United States

Preparation for End-of-Life Decision Making in Mild Dementia

Not Applicable

Completed

Conditions: Dementia

Interventions: Behavioral: SPIRIT-remote
Behavioral: Usual care
Behavioral: SPIRIT-in person

First Posted Date: 2017-10-17

Last Posted Date: 2023-04-11

Lead Sponsor: Emory University

Target Recruit Count: 242

Registration Number: NCT03311711

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Assisted Living Facilities in the Metro Atlanta Area, Atlanta, Georgia, United States
🇺🇸
Emory Clinic Geriatrics, Atlanta, Georgia, United States

and more 2 locations

The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention Project

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Behavioral: Health360x
Behavioral: Health Coach

First Posted Date: 2017-10-13

Last Posted Date: 2020-03-25

Lead Sponsor: Emory University

Target Recruit Count: 150

Registration Number: NCT03308812

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory University Clinical Research Network, Atlanta, Georgia, United States
🇺🇸
Morehouse School of Medicine, Clinical Research Center, Atlanta, Georgia, United States

Thyroid Ultrasound Elasticity (TrUE) Imaging

Completed

Conditions: Cancer, Thyroid

Interventions: Diagnostic Test: Ultrasound
Diagnostic Test: Shear wave elasticity imaging
Diagnostic Test: Multi-angle compound shear wave elasticity imaging

First Posted Date: 2017-10-12

Last Posted Date: 2019-12-03

Lead Sponsor: Emory University

Target Recruit Count: 31

Registration Number: NCT03307694

Locations: 🇺🇸
Emory Univeristy Hospital Midtown, Atlanta, Georgia, United States

Promoting Transactional Supports to Optimize Social Communication Outcomes for Infants and Their Families

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Parent-Implemented (P-I) Condition
Behavioral: Social Communication Growth Charts (SCGC)
Behavioral: Clinician-Implemented (C-I) Condition

First Posted Date: 2017-10-11

Last Posted Date: 2024-11-29

Lead Sponsor: Emory University

Target Recruit Count: 269

Registration Number: NCT03307057

Locations: 🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Phase 2

Recruiting

Conditions: Peripheral Artery Disease (PAD)

Interventions: Drug: Placebo
Drug: GM-CSF

First Posted Date: 2017-10-09

Last Posted Date: 2024-11-27

Lead Sponsor: Emory University

Target Recruit Count: 176

Registration Number: NCT03304821

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease

Phase 1

Withdrawn

Conditions: Sickle Cell Disease

Interventions: Biological: Autologous MSCs

First Posted Date: 2017-10-02

Last Posted Date: 2018-11-07

Lead Sponsor: Emory University

Registration Number: NCT03298399

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy